These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 22895899

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of ANCA-associated vasculitis: new therapies and a look at old entities.
    Zand L, Specks U, Sethi S, Fervenza FC.
    Adv Chronic Kidney Dis; 2014 Mar; 21(2):182-93. PubMed ID: 24602467
    [Abstract] [Full Text] [Related]

  • 4. Paediatric anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: an update on renal management.
    Plumb LA, Oni L, Marks SD, Tullus K.
    Pediatr Nephrol; 2018 Jan; 33(1):25-39. PubMed ID: 28062909
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. ANCA-associated vasculitides--advances in pathogenesis and treatment.
    Chen M, Kallenberg CG.
    Nat Rev Rheumatol; 2010 Nov; 6(11):653-64. PubMed ID: 20924413
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of ANCA-associated vascularitides].
    Guillevin L, Pagnoux C.
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [Abstract] [Full Text] [Related]

  • 10. B-cell depleting agents for ANCA vasculitides: a new therapeutic approach.
    Gómez-Puerta JA, Quintana LF, Stone JH, Ramos-Casals M, Bosch X.
    Autoimmun Rev; 2012 Jul; 11(9):646-52. PubMed ID: 22146313
    [Abstract] [Full Text] [Related]

  • 11. Rituximab versus cyclophosphamide for ANCA-associated vasculitis.
    Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U, RAVE-ITN Research Group.
    N Engl J Med; 2010 Jul 15; 363(3):221-32. PubMed ID: 20647199
    [Abstract] [Full Text] [Related]

  • 12. ANCA-Associated Vasculitis: Core Curriculum 2020.
    Geetha D, Jefferson JA.
    Am J Kidney Dis; 2020 Jan 15; 75(1):124-137. PubMed ID: 31358311
    [Abstract] [Full Text] [Related]

  • 13. Hallmark trials in ANCA-associated vasculitis (AAV) for the pediatric rheumatologist.
    Lee JJY, Alsaleem A, Chiang GPK, Limenis E, Sontichai W, Yeung RSM, Akikusa J, Laxer RM.
    Pediatr Rheumatol Online J; 2019 Jun 26; 17(1):31. PubMed ID: 31242923
    [Abstract] [Full Text] [Related]

  • 14. Rituximab in induction therapy for anti-neutrophil cytoplasmic antibody (ANCA) vasculitis.
    Niles J.
    Clin Exp Immunol; 2011 May 26; 164 Suppl 1(Suppl 1):27-30. PubMed ID: 21447128
    [Abstract] [Full Text] [Related]

  • 15. Targeted immunotherapy strategies in ANCA-associated vasculitis.
    Puéchal X.
    Joint Bone Spine; 2019 May 26; 86(3):321-326. PubMed ID: 30201478
    [Abstract] [Full Text] [Related]

  • 16. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab.
    Cartin-Ceba R, Fervenza FC, Specks U.
    Curr Opin Rheumatol; 2012 Jan 26; 24(1):15-23. PubMed ID: 22089095
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.